From the Sector

Reset
138 results
30.06.2020

Autoneum realigns financing sustainably

Due to the COVID 19 crisis and its significant impact on the automotive industry and Autoneum's course of business, the Company and a bank consortium have amended the existing long-term credit agreement in the amount of CHF 350 million, amongst others with regard to the financial covenants.

At the same time, the two major shareholders Michael Pieper and Peter Spuhler have  agreed to extend the term of the subordinated loans of CHF 20 million each, granted in December 2019, subject to the financial performance of Autoneum Group and aligned with the credit agreement with the bank syndicate. As a result, Autoneum's liquidity and long-term financing continue to be secured on a sustainable basis.

Due to the COVID 19 crisis and its significant impact on the automotive industry and Autoneum's course of business, the Company and a bank consortium have amended the existing long-term credit agreement in the amount of CHF 350 million, amongst others with regard to the financial covenants.

At the same time, the two major shareholders Michael Pieper and Peter Spuhler have  agreed to extend the term of the subordinated loans of CHF 20 million each, granted in December 2019, subject to the financial performance of Autoneum Group and aligned with the credit agreement with the bank syndicate. As a result, Autoneum's liquidity and long-term financing continue to be secured on a sustainable basis.

More information:
Covid-19 Autoneum
Source:

Autoneum Management AG

24.06.2020

BVMed: Unterstützung zum Aufbau strategischer Medizinprodukte-Reserve

Der Bundesverband Medizintechnologie (BVMed) hat der Bundesregierung und der Europäischen Kommission im Rahmen der deutschen EU-Ratspräsidentschaft eine enge Zusammenarbeit beim Aufbau einer europaweiten strategischen Reserve für Medizinprodukte angeboten.

"Wir stehen für smarte Lösungen bereit. Wir können die Herausforderung durch die intelligente Nutzung bestehender Lagerkapazitäten mit einem rotierenden System meistern", so BVMed-Geschäftsführer Dr. Marc-Pierre Möll. Die vorhandenen Lagerkapazitäten unter anderem der Hersteller könnten online vernetzt und intelligent gesteuert werden. "Das System ist kostengünstig, schnell umsetzbar und für den Katastrophenschutz sehr effizient." Zudem spricht sich der BVMed für einen "europäischen Pandemieplan" aus, um innerhalb Europas eine erneute Schließung der Grenzen zu verhindern.

Der Bundesverband Medizintechnologie (BVMed) hat der Bundesregierung und der Europäischen Kommission im Rahmen der deutschen EU-Ratspräsidentschaft eine enge Zusammenarbeit beim Aufbau einer europaweiten strategischen Reserve für Medizinprodukte angeboten.

"Wir stehen für smarte Lösungen bereit. Wir können die Herausforderung durch die intelligente Nutzung bestehender Lagerkapazitäten mit einem rotierenden System meistern", so BVMed-Geschäftsführer Dr. Marc-Pierre Möll. Die vorhandenen Lagerkapazitäten unter anderem der Hersteller könnten online vernetzt und intelligent gesteuert werden. "Das System ist kostengünstig, schnell umsetzbar und für den Katastrophenschutz sehr effizient." Zudem spricht sich der BVMed für einen "europäischen Pandemieplan" aus, um innerhalb Europas eine erneute Schließung der Grenzen zu verhindern.

Hintergrund der BVMed-Initiative ist, dass in der Sitzung des Koalitionsausschusses vom 3. Juni 2020, in der Besprechung der Bundeskanzlerin mit den Ländern am 17. Juni 2020 und auch auf europäischer Ebene das Thema Aufbau einer strategischen Reserve von persönlicher Schutzausrüstung und Medizinprodukten für die Intensivmedizin auf der Tagesordnung steht.

Aus Sicht des deutschen MedTech-Verbandes hat die COVID-19-Krise gezeigt, dass Deutschland und die EU Gefahr laufen, sich abhängig zu machen, wenn sich die Produktion wichtiger Güter des medizinischen Bedarfs auf nur wenige außereuropäische Länder konzentriert. "Um dies anzugehen, muss die EU zunächst zusammen mit den Herstellern etwaige Schwachstellen in den Lieferketten untersuchen. Um zukünftige Engpässe zu vermeiden, sollte die EU zudem ihren Vorrat an medizinischer Ausrüstung erweitern und den Mitgliedsstaaten zur Verfügung stellen, die ihn benötigen", so Möll. Der BVMed-Vorschlag: Eine europäische strategische Reserve von Medizinprodukten kann durch eine intelligente Nutzung und eine Onlinesteuerung der bestehenden Lagerkapazitäten aufgebaut werden. "Probleme mit der Haltbarkeit der Produkte gibt es dann nicht, weil die Lager regelmäßig umgeschlagen werden", so der BVMed.

Während der Corona-Pandemie kam es zudem zu zahlreichen Lieferengpässen bei Rohstoffen, die für die Herstellung vieler Medizinprodukte und Arzneimittel zwingend erforderlich sind. Ein Aufbau einer strategischen Rohstoff-Reserve durch Medizinprodukte- und Arzneimittelhersteller für mehrere Monate bedeute aus BVMed-Sicht einen vergleichsweise geringen Aufwand und überschaubare Lagerkosten. Für die einmaligen Zusatzkosten, die durch den initialen Aufbau der Reserven entstehen, könnte ein Ausgleichsmechanismus gefunden werden.

Erforderlich hält der BVMed auch die Bereithaltung eines intensivmedizinischen Produktportfolios für mehrere Monate. "Von staatlicher Seite muss in Abstimmung mit medizinischen Fachgesellschaften und den Herstellern ein intensivmedizinisches Produktportfolio definiert und für einen zu bestimmenden Zeitraum bereitgehalten werden, das über persönliche Schutzausrüstung hinausgeht", fordert der BVMed. Dabei könnte in Verträgen zwischen Bund und Herstellern vereinbart werden, vorab definierte Produkte und Mengen für eine bestimmte Reichweite dauerhaft im Bestand der jeweiligen Hersteller vorzuhalten.

BVMed-Geschäftsführer Dr. Marc-Pierre Möll: "Die Unternehmen verfügen über Kompetenz und etablierte Logistikprozesse, um Gesundheitseinrichtungen kontinuierlich und zuverlässig mit benötigten Medizinprodukten und Arzneimitteln zu beliefern. Darüber hinaus findet damit nach dem Prinzip first-in-first-out eine nachhaltige und ressourcenschonende Umwälzung der Bestände statt, ohne dass eine Vernichtung nach Ablauf von Verfallsdaten bei einigen Produkten notwendig würde."

More information:
BVMed
Source:

BVMed - Bundesverband Medizintechnologie e.V.

Photo: Shutterstock
18.06.2020

VDMA starts technology webtalks for the textile industry

On June 22, the VDMA starts a series of Textile Machinery Webtalks. In the first edition experts from the companies Oerlikon Manmade Fibers, Mahlo and Nanoval will present technologies for the production of melt-blown nonwovens for respiratory protection masks (FFP masks and surgical masks). After the presentations, the experts will be available to answer the participants' questions. The webtalk will run from 2 – 4 pm (German time). Participation is free of charge. Interested persons can register here

Further technology webtalks on other topics are in preparation. Please check 
www.machines-for-textiles.com/webtalk for updates.
 

On June 22, the VDMA starts a series of Textile Machinery Webtalks. In the first edition experts from the companies Oerlikon Manmade Fibers, Mahlo and Nanoval will present technologies for the production of melt-blown nonwovens for respiratory protection masks (FFP masks and surgical masks). After the presentations, the experts will be available to answer the participants' questions. The webtalk will run from 2 – 4 pm (German time). Participation is free of charge. Interested persons can register here

Further technology webtalks on other topics are in preparation. Please check 
www.machines-for-textiles.com/webtalk for updates.
 

More information:
VDMA
Source:

VDMA 
Textile Machinery

18.06.2020

Befristete USt-Reduzierung: BVMed fordert Klarheit für Hilfsmittelversorgung

Der Bundesverband Medizintechnologie, BVMed, hat den GKV-Spitzenverband aufgefordert, den bürokratischen Aufwand der zeitlich befristeten Umsatzsteuer-Absenkung für die Hilfsmittel-Leistungserbringer zu reduzieren.

"Die kurzfristige und zeitlich befristete Umsatzsteuerabsenkung ab dem 1. Juli 2020 bedeutet für die MedTech-Unternehmen einen erheblichen Umstellungs- und Mehraufwand", so BVMed-Geschäftsführer Dr. Marc-Pierre Möll. Der BVMed spricht sich deshalb für begleitende Maßnahmen aus, um die Umsetzung möglichst unbürokratisch zu vollziehen. "Für den Bereich der Hilfsmittel-Versorgungen und -Abrechnungen sehen wir den GKV-Spitzenverband in der Verantwortung, handhabbare Umsetzungsregelungen zu schaffen", sagt BVMed-Hilfsmittelexpertin Juliane Pohl.

Der Bundesverband Medizintechnologie, BVMed, hat den GKV-Spitzenverband aufgefordert, den bürokratischen Aufwand der zeitlich befristeten Umsatzsteuer-Absenkung für die Hilfsmittel-Leistungserbringer zu reduzieren.

"Die kurzfristige und zeitlich befristete Umsatzsteuerabsenkung ab dem 1. Juli 2020 bedeutet für die MedTech-Unternehmen einen erheblichen Umstellungs- und Mehraufwand", so BVMed-Geschäftsführer Dr. Marc-Pierre Möll. Der BVMed spricht sich deshalb für begleitende Maßnahmen aus, um die Umsetzung möglichst unbürokratisch zu vollziehen. "Für den Bereich der Hilfsmittel-Versorgungen und -Abrechnungen sehen wir den GKV-Spitzenverband in der Verantwortung, handhabbare Umsetzungsregelungen zu schaffen", sagt BVMed-Hilfsmittelexpertin Juliane Pohl.

Die vorübergehende Senkung der Mehrwertsteuer wird von den in der Interessengemeinschaft Hilfsmittelversorgung (IGHV) zusammengeschlossenen Hersteller- und Leistungserbringerverbänden, wie dem BVMed, grundsätzlich begrüßt. Allerdings sorgt die ab 1. Juli bis 31. Dezember 2020 geltende Maßnahme im Rahmen der Hilfsmittelversorgung und -abrechnung für immense Aufwände auf Seiten der Leistungserbringer. "Die befristete Umsatzsteuerabsenkung bedeutet für die Hilfsmittel-Leistungserbringer und Homecare-Unternehmen einen enormen bürokratischen und finanziellen Mehraufwand. Sämtliche Verträge und insbesondere die Abrechnungssysteme müssen vorübergehend angepasst werden", so Pohl. "Vor allem aber braucht es Klarheit, wie sich die Steueranpassungen in den Genehmigungs- und Abrechnungsprozessen abbilden lassen." Die Krankenkassenseite müsse deshalb gemeinsame Regeln schaffen, die die bestehenden Unklarheiten beheben und dabei den Aufwand für alle Beteiligten möglichst gering halten.

Insbesondere sei aus Sicht der Hilfsmittel-Unternehmen sicherzustellen, dass ungeklärte, diffuse oder variierende technische oder administrative Umsetzungs-Anforderungen nicht zu Absetzungen der Versorgung führen – "beispielsweise wenn aufgrund abweichender Steuersätze der genehmigte Kostenvoranschlag von der Abrechnung abweicht. Oder wenn mehrmonatige Abrechnungen aufgrund variierender Steuersätze gesplittet durchgeführt werden müssten, obwohl sie eventuell vertraglich anders vereinbart sind", erklärt Pohl. Für derlei Fälle sind aus Sicht des BVMed einheitliche Umsetzungshinweise durch den GKV-Spitzenverband erforderlich. Regelungsbedarf sieht der BVMed zudem bei der Umsetzung monatsübergreifender Versorgungen, die sich über einen Zeitraum erstrecken, in denen unterschiedliche Steuersätze gelten.

More information:
BVMed Umsatzsteuer
Source:

BVMed - Bundesverband Medizintechnologie e.V.

12.06.2020

USt-Absenkung: BVMed für unbürokratische Umsetzung

Der Bundesverband Medizintechnologie, BVMed, sieht in seiner Stellungnahme zum "Zweiten Corona-Steuerhilfegesetz" Änderungsbedarf bei der geplanten Absenkung der Umsatzsteuersätze. Da die kurzfristige und temporäre Absenkung einen enormen Umsetzungsaufwand bedeutet, spricht sich der BVMed für ein entsprechendes Begleitschreiben des Bundesfinanzministeriums "zur unbürokratischen Umsetzung und Nichtbeanstandungsregelungen" aus. "Wir müssen die kurzfristige Umsetzung der Umsatzsteuerabsenkung praktikabel und wirklichkeitsnah gestalten", so BVMed-Geschäftsführer Dr. Marc-Pierre Möll.

Der Bundesverband Medizintechnologie, BVMed, sieht in seiner Stellungnahme zum "Zweiten Corona-Steuerhilfegesetz" Änderungsbedarf bei der geplanten Absenkung der Umsatzsteuersätze. Da die kurzfristige und temporäre Absenkung einen enormen Umsetzungsaufwand bedeutet, spricht sich der BVMed für ein entsprechendes Begleitschreiben des Bundesfinanzministeriums "zur unbürokratischen Umsetzung und Nichtbeanstandungsregelungen" aus. "Wir müssen die kurzfristige Umsetzung der Umsatzsteuerabsenkung praktikabel und wirklichkeitsnah gestalten", so BVMed-Geschäftsführer Dr. Marc-Pierre Möll.

Der deutsche MedTech-Verband begrüßt grundsätzlich die vom Koalitionsausschuss beschlossenen Maßnahmen zur Förderung der Wirtschaft und von Innovationen. Dies betreffe insbesondere die Maßnahmen zur Bevorratung von Schutzausrüstung, zur größeren strategischen Unabhängigkeit der Produktion von Medizinprodukten und das "Zukunftsprogramm Krankenhäuser", das in die Verbesserung der Notfallkapazitäten und der digitalen Infrastruktur investiere. Auch die Wiedereinführung einer degressiven Abschreibungsmöglichkeit für Neuinvestitionen und die Ausweitung der steuerlichen Forschungszulage bewertet der BVMed positiv.

Grundsätzlich spricht sich der BVMed dafür aus, Medizinprodukte bzw. Hilfsmittel einheitlich und dauerhaft mit dem ermäßigten Steuersatz zu besteuern – und damit Ärzte, Kliniken, Krankenkassen und Patienten zu entlasten. Das Problem: "Aktuell werden Medizinprodukte unterschiedlich besteuert. Das führt in der Praxis immer wieder zu Abgrenzungsschwierigkeiten und Wertungswidersprüchen", so der BVMed. Ein weiteres Anliegen des Verbandes sind praxistaugliche Regeln bei der temporären Absenkung der Mehrwertsteuer für die Versorgung von gesetzlich Krankenversicherten mit Hilfsmitteln, Verbandmitteln zur Versorgung chronischer Wunden und speziellen Lebensmitteln zur medizinischen Ernährung.

More information:
BVMed
Source:

BVMed - Bundesverband Medizintechnologie e.V.

Cifra, Iluna Group, Rosti and Sitip launch fashionable masks with ROICA™ (c) Sitip-Rosti
Sitip Rosti Mask
08.06.2020

Cifra, Iluna Group, Rosti and Sitip launch fashionable masks with ROICA™

Masks yes, but with comfort, safety and also style: Cifra, Iluna Group, Rosti and Sitip launch masks with a fashion touch with the premium stretch fiber ROICA™
 
Big companies are updating their productions with high-performance and high technical characteristics masks, result of their historical experience and thanks to an exceptional partner in common: the premium stretch fiber ROICA™ by Asahi Kasei. And the solidarity race continues to donate them to hospitals and to the Red Cross
 
Forced to keep most of the face covered and often for a long time during the day, solutions that are above all performing and comfortable become increasingly necessary.

Masks yes, but with comfort, safety and also style: Cifra, Iluna Group, Rosti and Sitip launch masks with a fashion touch with the premium stretch fiber ROICA™
 
Big companies are updating their productions with high-performance and high technical characteristics masks, result of their historical experience and thanks to an exceptional partner in common: the premium stretch fiber ROICA™ by Asahi Kasei. And the solidarity race continues to donate them to hospitals and to the Red Cross
 
Forced to keep most of the face covered and often for a long time during the day, solutions that are above all performing and comfortable become increasingly necessary.

And solutions that are also a manifestation of our personality, which remains hidden and entrusted to the mere expression of the eyes. Walking on the streets we sometimes even don’t even recognize each other, since we are so hidden; and the desire to minimize the situation often takes over, together with that desire to make us recognizable, to possess and express an identity anyway. For fans of escaping homologation (now more than ever mandatory and for this reason even more difficult) “rescue comes” - and this is the case to say it - from illuminated companies who have thought about creative solutions for those with masks has to do all day, at home, at work, during sports and in leisure time. To feel more comfortable, there are many proposals: more “street style” for sports addicted and young people - inside and outside -, more elegant and sophisticated for women.

Textiles companies have joined the fight against Covid-19 engaging a strong and decisive personal and productive battle, which has seen many of them transform and convert their production units for the production of masks and gowns intended for medical personnel and the community.

Some of the most established excellences of the textile sector as Cifra, Iluna Group, Rosti and Sitip have made use of the precious collaboration of ROICA™, the premium stretch fiber by Asahi Kasei. ROICA™ is the innovative and smart premium ingredient chosen by these companies to guarantee even more comfort, thanks to an exceptional top-level component that gives elasticity for perfect adherence to the skin. Each of the companies then declined its production according to its specificity. And this is their important contribution.

Cifra presents the eco-sustainable version of the mask, the ECO-MASK™, which combines the high performance of Cifra knitting technology with the sustainability of the materials used. The 100% regenerated yarns create a 100% sustainable mask with 83% ECONYL and 17% ROICA™ V550 elastomer, the stretch fiber certified Cradle to Cradle Gold Health Level which allows excellent and lasting printability, as well as advantages regarding the circular economy as it does not release harmful substances into the test environment according to the Hohenstein Environmental Compatibility certification.

Iluna Group, European leader in the production of lace, has recently donated 400 protective “smart”  made with ROICA™ EF, the world first GRS - Global Recycled Standard – certified elastomer and which uses 58% of pre-consumer recycled content, mixed with Q-NOVA® by Fulgar. Multi-use, washable, bacteriostatic, breathable and water-repellent prevention masks gave to San Gerardo Hospital in Monza to answer to the Call to action launched on March 19th by the green journalist Diana De Marsanich, with the responsible and innovative materials expert Giusy Bettoni of C.L.A.S.S. Eco Hub, the fashion designer Marina Spadafora of Fashion Revolution Italia and the entrepreneur Simona Roveda of LifeGate. Iluna Group also announces the launch of the website dedicated to the direct sale of the different kind of masks all made with three layers, antibacterial and anti-drip treatment and washable up to 10 times. Iluna Group has also created the “smart” masks made with ROICA™ EF, the world first GRS - Global Recycled Standard – certified elastomer and which uses 58% of pre-consumer recycled content, mixed with Q-NOVA® by Fulgar.

In addition to the “smart” masks, available for women, men and children, Iluna Group has created two special versions of Lace Masks, covered with refined lace. One embroidered on a cotton base and one with soft microfiber.

Rosti, historic knitwear factory based in Brembate specialized in the design and production of cycling clothing with the best technical fabrics and the most advanced technologies, has put its experience at the service of the production of protective masks washable up to 20 times, made with Sitip fabric and with the anti-drop treatment Ecoacquazero®. Fascinating and protective like a second skin, the masks are sold in a pack of 10 pieces with captivating, colorful, geometric and original graphics, designed for every personality.

Rosti masks contain the premium stretch fiber ROICA™ Resistance, a family of premium stretch yarn with particular performances of resistance and durability.

28.05.2020

Rieter: Business Situation facing COVID-19 Pandemic

  • Since the end of March 2020, COVID-19 has led to very low demand in all Business Groups
  • Comprehensive crisis management implemented
  • Loss in the mid double-digit million range expected in the first half of 2020
  • Plans to introduce short-time working to adjust capacity in Switzerland and Germany
  • Strategy will continue to be implemented

Due to COVID-19, a large number of spinning mills have stopped production worldwide. Since the end of March 2020, this has led to low demand for spare parts and wear & tear parts and delays in testing programs during the development of new machines. Customers are postponing investment projects or unable to implement them due to restrictions imposed by national governments. This results in low demand for new machines.

  • Since the end of March 2020, COVID-19 has led to very low demand in all Business Groups
  • Comprehensive crisis management implemented
  • Loss in the mid double-digit million range expected in the first half of 2020
  • Plans to introduce short-time working to adjust capacity in Switzerland and Germany
  • Strategy will continue to be implemented

Due to COVID-19, a large number of spinning mills have stopped production worldwide. Since the end of March 2020, this has led to low demand for spare parts and wear & tear parts and delays in testing programs during the development of new machines. Customers are postponing investment projects or unable to implement them due to restrictions imposed by national governments. This results in low demand for new machines.

Comprehensive crisis management
Rieter has implemented comprehensive crisis management. Priorities are being given to protecting employees, fulfilling customer commitments and ensuring liquidity. The necessary measures to protect employees have been implemented worldwide.
The order backlog of well in excess of CHF 500 million is being processed largely according to plan, despite the existing bottlenecks in the supply chains. Less than 5% of the orders in the order backlog have been canceled.
Rieter has already implemented measures to ensure liquidity and reduce costs. The company has good net liquidity and undrawn credit lines in the mid three-digit million range.
Loss expected in the first half of 2020
As already reported, Rieter expects sales and earnings in the first half of 2020 to be significantly below the prior year level.

Loss expected in the first half of 2020
As already reported, Rieter expects sales and earnings in the first half of 2020 to be significantly below the prior year level. The effects of COVID-19 will place an additional burden on the first half of 2020. Rieter therefore expects sales in the first half of 2020 to be less than CHF 300 million. Despite the countermeasures implemented at the net profit level, this will lead to a loss in the mid double-digit million range.

Plans to introduce short-time working to adjust capacity
Rieter plans to apply for short-time working for the areas with forecasted low capacity utilization at the locations in Switzerland and Germany. The application will be for 40% short-time working in the third quarter of 2020. Talks with staff representatives will begin next week.
As a sign of solidarity, Rieter’s Board of Directors, Group Executive Committee and the senior management will waive 10%-20% of their salaries temporarily.

Implementation of the strategy
In recent years, Rieter has consistently implemented the strategy based on innovation leadership, strengthening the business in components, spare parts and services and the adjustment of cost structures. The company intends to forge ahead with the implementation of the strategy in the coming months, thus strengthening its market position for the time after the COVID-19 pandemic.
The next information on the course of business is planned with the publication of the half-year results on July 16, 2020
 

More information:
Coronavirus Rieter
Source:

Rieter Holding AG

27.05.2020

Huntsman Textile Effects and Bao Minh Textile collaborating

  • Producing fabric for medical gowns: Advanced barrier effect solutions support COVID-19 efforts

Huntsman Textile Effects and Bao Minh Textile, one of the largest and most modern woven fabric producers in Vietnam, are collaborating to produce fabric that meets the stringent performance standards required of isolation gowns. High-quality medical gowns are essential protective wear for healthcare workers combatting the global COVID-19 pandemic, but these are in short supply worldwide.

Bao Minh Textile will initially treat 760,000 meters of woven fabric with a carefully curated combination of Huntsman Textile Effects barrier effect solutions and auxiliaries. This fabric is sufficient to produce 345,000 high-grade isolation gowns.

  • Producing fabric for medical gowns: Advanced barrier effect solutions support COVID-19 efforts

Huntsman Textile Effects and Bao Minh Textile, one of the largest and most modern woven fabric producers in Vietnam, are collaborating to produce fabric that meets the stringent performance standards required of isolation gowns. High-quality medical gowns are essential protective wear for healthcare workers combatting the global COVID-19 pandemic, but these are in short supply worldwide.

Bao Minh Textile will initially treat 760,000 meters of woven fabric with a carefully curated combination of Huntsman Textile Effects barrier effect solutions and auxiliaries. This fabric is sufficient to produce 345,000 high-grade isolation gowns.

Bao Minh Textile’s isolation gown fabric relies on a range of Huntsman pretreatment, dyeing and finishing solutions. These include CLARITE® ONE, an all-in-one pretreatment for peroxide bleaching; NOVACRON® and TERASIL® dyes; PHOBOL® CP-C, an excellent oil-, water- and stain-repellent finish; and PHOBOTEX® RSY, a non-fluorinated durable water repellent with extremely high washing resistance. PHOBOL® EXTENDER XAN is also applied to further increase wash durability.

 

Source:

Huntsman Textile Effects

The Oerlikon Nonwoven meltblown technology (c) Oerlikon
The Oerlikon Nonwoven meltblown technology
14.05.2020

Oerlikon Nonwoven deliveringmeltblown technology to FleeceforEurope

Protective masks for Europe
With FleeceforEurope and Lindenpartner, Düsseldorf-based Kloepfel Group purchasing consultancy and Berlin-based industrial consultancy Bechinger & Heymann Holding plan to manufacture and distribute up to 50 million protection class FFP1 through FFP3 respiratory masks a month exclusively for the European market from the beginning of fall. And the primary focus will be on quality.
With protective masks – including those used in operating rooms – this quality is provided above all by  virus-absorbing nonwovens. And these will be manufactured by ‘FleeceforEurope’ using an Oerlikon Nonwoven meltblown system.
But masks effectively protecting against infections can only be guaranteed with the right quality. A crucial factor in this is the inside of the mask. Because the nonwoven used in protection class FFP1 through FFP3 respiratory masks plays a decisive role.

Protective masks for Europe
With FleeceforEurope and Lindenpartner, Düsseldorf-based Kloepfel Group purchasing consultancy and Berlin-based industrial consultancy Bechinger & Heymann Holding plan to manufacture and distribute up to 50 million protection class FFP1 through FFP3 respiratory masks a month exclusively for the European market from the beginning of fall. And the primary focus will be on quality.
With protective masks – including those used in operating rooms – this quality is provided above all by  virus-absorbing nonwovens. And these will be manufactured by ‘FleeceforEurope’ using an Oerlikon Nonwoven meltblown system.
But masks effectively protecting against infections can only be guaranteed with the right quality. A crucial factor in this is the inside of the mask. Because the nonwoven used in protection class FFP1 through FFP3 respiratory masks plays a decisive role.
Here, the meltblown technology from Oerlikon Nonwoven will be deployed. In a special, patented process, the fibers laid into a nonwoven fabric during manufacture are subsequently electrostatically-charged, before the material is further processed downstream.

European market for protective masks with a promising future
Those responsible at Oerlikon Nonwoven and FleeceforEurope, which will primarily focus on producing high-end nonwovens, and Lindenpartner, which will manufacture and distribute the protective masks, are certain of one thing: the market for protective masks has a very promising long-term future in Europe.
What has been commonplace in Asia for many years now will also become normal in Europe. People will be increasingly wearing face masks when venturing out, in order to better protect themselves against health risks such as the current pandemic and also against increasing environmental pollution in the form of  fine particles and exhaust fumes in the future. A

Medical face masks from a vending machine
Mask producer Lindenpartner has already secured supplies of nonwovens and will be producing face masks for the European healthcare sector over the coming weeks. To fight the coronavirus pandemic, Lindenpartner is planning to install 100 self-service face mask vending machines in Germany over the next four weeks, positioning them in publicly-accessible places such as shopping centers and airports, for example.

Source:

Marketing, Corporate Communications & Public Affairs

07.05.2020

BVMed-Appell zur Anhörung des 2. Bevölkerungsschutz-Gesetzes

  • "Komplexe Medizinprodukte-Lieferketten beachten"

Der Bundesverband Medizintechnologie, BVMed, appelliert im Vorfeld der Anhörung zum Zweiten Bevölkerungsschutzgesetz, auch in Krisenzeiten die marktwirtschaftlichen Prinzipien und die komplexen Lieferketten und Produktionsnetzwerke der MedTech-Branche zu beachten, um Versorgungsengpässe zu vermeiden. "Wichtig ist, dass die komplexen Liefer- und Versorgungsketten unserer Branche nicht durch staatliche Eingriffe wie Beschlagnahme oder Exportbeschränkungen beeinträchtigt werden", so BVMed-Geschäftsführer Dr. Marc-Pierre Möll.

  • "Komplexe Medizinprodukte-Lieferketten beachten"

Der Bundesverband Medizintechnologie, BVMed, appelliert im Vorfeld der Anhörung zum Zweiten Bevölkerungsschutzgesetz, auch in Krisenzeiten die marktwirtschaftlichen Prinzipien und die komplexen Lieferketten und Produktionsnetzwerke der MedTech-Branche zu beachten, um Versorgungsengpässe zu vermeiden. "Wichtig ist, dass die komplexen Liefer- und Versorgungsketten unserer Branche nicht durch staatliche Eingriffe wie Beschlagnahme oder Exportbeschränkungen beeinträchtigt werden", so BVMed-Geschäftsführer Dr. Marc-Pierre Möll.

Mit dem Bevölkerungsschutzgesetz überträgt der Gesetzgeber dem Bundesgesundheitsministerium erhebliche Kompetenzen und Eingriffsrechte. So kann das Ministerium durch Rechtsverordnung ohne Zustimmung des Bundesrates Maßnahmen zur Sicherstellung der Versorgung mit Arzneimitteln oder Medizinprodukten treffen. Dem Gesetzentwurf selbst ist aber nicht zu entnehmen, dass die Maßnahmen jeweils im unmittelbaren Zusammenhang mit der epidemischen Lage von nationaler Tragweite stehen müssen. "Das heißt, dass bei der Anwendung und Auslegung der Norm ein Spielraum zur Umsetzung gegeben ist", bemängelt der BVMed in seiner Stellungnahme. Der BVMed fordert daher eine Klarstellung, dass die umfangreichen Eingriffsrechte nur im unmittelbaren Zusammenhang mit einer epidemischen Lage von nationaler Tragweite und einer daraus unmittelbar resultierenden Notlage bei der gesundheitlichen Versorgung erfolgen dürfen. "Anders gelagerte Fälle, die zu Lieferengpässen führen könnten, sollten nicht unter diese Normen mit ihren erheblichen Eingriffsrechten in den Vertrieb oder die Preisgestaltung medizinischer Güter gefasst werden", heißt es in der BVMed-Stellungnahme.

Source:

BVMed - Bundesverband Medizintechnologie e.V.

06.05.2020

CHT teams up with HeiQ in fight against COVID-19

The corona pandemic continues to put a strain on health systems around the globe. Many places lack effective textile protective kit among others for their medical personnel. HeiQ, a Swiss specialty chemicals company, has developed antiviral and antibacterial protective kit that is quickly effective against Coronaviruses (229E), as confirmed in wide-ranging studies. In cooperation with HeiQ, the CHT Group is supplying this technology to the market to help decrease the global shortage in protective wear.

A wide number of studies have proven that viruses and bacteria can remain active on textile surfaces for a longer period. The SARS-COV-2 virus, which causes the COVID-19 disease, can stay active on a textile for up to two days and therefore be infectious. Shortages in textile protective kit create a high risk for medical personnel who are in contact with COVID-19 patients: often, doctors and nurses cannot change their protective masks and clothing as frequently as would be necessary in order to adhere to hygiene rules and to prevent the spreading of the virus.

The corona pandemic continues to put a strain on health systems around the globe. Many places lack effective textile protective kit among others for their medical personnel. HeiQ, a Swiss specialty chemicals company, has developed antiviral and antibacterial protective kit that is quickly effective against Coronaviruses (229E), as confirmed in wide-ranging studies. In cooperation with HeiQ, the CHT Group is supplying this technology to the market to help decrease the global shortage in protective wear.

A wide number of studies have proven that viruses and bacteria can remain active on textile surfaces for a longer period. The SARS-COV-2 virus, which causes the COVID-19 disease, can stay active on a textile for up to two days and therefore be infectious. Shortages in textile protective kit create a high risk for medical personnel who are in contact with COVID-19 patients: often, doctors and nurses cannot change their protective masks and clothing as frequently as would be necessary in order to adhere to hygiene rules and to prevent the spreading of the virus.

The HeiQ Viroblock NPJ03 that has been developed by HeiQ is a new technology that is also effective against Coronaviruses (229E) thanks to its antibacterial and antiviral properties. Comprehensive studies have demonstrated the kit‘s effectiveness. A combination of silver salts with a vesicle technology deactivates bacteria and viruses on textile surfaces within a few minutes and renders the bacteria and viruses harmless. Textiles equipped in this way reduce the rate of infection by 99.99%, which stops the transmission and the spread of bacteria and viruses through textiles.

Viroblock can be used on all types of fibers – not only for protective kit and masks, but also for work clothing, bed linen, towels and home textiles. The kit is wash-resistant and still highly effective after 30 standard wash processes.

More information:
HeiQ CHT Group corona virus
Source:

CHT Gruppe

CHIC zum ersten Mal digital (c) CHIC ONLINE
(c) CHIC ONLINE
04.05.2020

CHIC zum ersten Mal digital

  • CHIC ONLINE vom 22. bis 24. April 2020
  • Erfolgreiche Premiere der digitalen Ausgabe der CHIC vom 22.-24. April 2020
  • Mehr als 1.350 Austeller nahmen an den über 100 Online-Aktivitäten der Messe teil
  • Alle Vertriebskanäle des chinesischen Handels waren auf der Plattform vertreten
  • Im Fokus der Kunden: innovatives, kreatives Design und hochwertige Produkte

1.350 teilnehmende Aussteller, über 100 Online-Aktivitäten, über 60 Live-Medienberichte, bis zu 157.403 Besuche verzeichnete die erste CHIC ONLINE vom 22. bis 24. April 2020.

Die aktuell weltweit schwierige wirtschaftliche Situation durch die Corona-Pandemie läßt die Unternehmen nach neuen Lösungsansätzen für ihre Geschäftsmöglichkeiten suchen.
CHIC, China International Fashion Fair, hat mit CHIC ONLINE, ihrer ersten digitalen Messe, an drei Tagen die Möglichkeit geboten, sich mit Entscheidern des chinesischen Modehandels zu vernetzen, sich auszutauschen und Ressourcen zu bündeln.

  • CHIC ONLINE vom 22. bis 24. April 2020
  • Erfolgreiche Premiere der digitalen Ausgabe der CHIC vom 22.-24. April 2020
  • Mehr als 1.350 Austeller nahmen an den über 100 Online-Aktivitäten der Messe teil
  • Alle Vertriebskanäle des chinesischen Handels waren auf der Plattform vertreten
  • Im Fokus der Kunden: innovatives, kreatives Design und hochwertige Produkte

1.350 teilnehmende Aussteller, über 100 Online-Aktivitäten, über 60 Live-Medienberichte, bis zu 157.403 Besuche verzeichnete die erste CHIC ONLINE vom 22. bis 24. April 2020.

Die aktuell weltweit schwierige wirtschaftliche Situation durch die Corona-Pandemie läßt die Unternehmen nach neuen Lösungsansätzen für ihre Geschäftsmöglichkeiten suchen.
CHIC, China International Fashion Fair, hat mit CHIC ONLINE, ihrer ersten digitalen Messe, an drei Tagen die Möglichkeit geboten, sich mit Entscheidern des chinesischen Modehandels zu vernetzen, sich auszutauschen und Ressourcen zu bündeln.

„Der Start der CHIC ONLINE ist ein historischer Tag für CHIC, die nach ihrer Gründung vor 28 Jahren hiermit zum ersten Mal online gegangen ist.“ Chen Dapeng, Präsident der China National Garment Association und CHIC, Vizepräsident der China Textile Industry Federation.

Mehr als 1.350 Hersteller haben ihre Angebote in die Online-Meeting-Räume von Tencent Meeting und Ding Talk hochgeladen und an den über 100 Online-Meeting-Aktivitäten von CHIC ONLINE teilgenommen. Die über Jahrzehnte gesammelten Ressourcen der CHIC, ihr Netzwerk und ihre Erfahrungen beim Informationsaustausch sind bei dem Event zum Tragen gekommen. CHIC ONLINE ist ein positiver Ansatz für die digitale Transformation der Messe und gleichzeitig ein pragmatischer Schritt die Geschäftskanäle und Ressourcen miteinander zu verknüpfen.

In dieser speziellen Zeit ist CHIC ONLINE für die gesamte chinesische Bekleidungsindustrie und ihre internationalen Teilnehmer kostenfrei geöffnet gewesen, als Unterstützungsmaßnahme der CHIC für Chinas Mode- und Lifestyle-Industrie.

Die Online-Messehalle unterteilte sich in die Segmente Men, Women, Impulses (Designer), KIDZ, Winter (Leder und Pelz, Daunen), CHIC YOUNG BLOOD (Streetwear), Tailoring (Bespoke), Accessoires, Taschen und Schuhe, Fashion Journey (internationale Marken) und Sourcing. Die Meeting-Räume waren klar nach Angebot und Nachfrage strukturiert, eine direkte Brücke für die Kommunikation in Echtzeit.
Alle Kanäle des chinesischen Handels waren bei CHIC ONLINE vertreten: E-Commerce Plattformen wie Tmall, Jingdong, VIP Shop, oder NetEase Yeaton (Chinas "Muji"), eine der beliebtesten Online-Plattformen in China und Biyao Shop - ursprünglich gegründet als Verkaufsplattform für Luxusprodukte direkt vom Hersteller zu günstigeren Preisen - mit mittlerweile 20 Millionen Abonnenten, über 80.000 Bestellungen täglich.

Department Stores wie die Wangfujing-Gruppe, Weifang Department Store Group, LiQun Gruppe nutzten CHIC ONLINE für die Suche nach neuen Marken genauso wie zahlreiche Multi-brand Boutiquen darunter HANATEBAKO Designer Brand Collection Store aus Qingdao, dessen Direktor Jiang Shixiang in der Angebotsvielfalt und Diversifikation der Kategorien die Zukunft der Offline-Stores im chinesischen Markt sieht. Besonders die Segmente Accessoires und Schuhe seien für die Boutiquen wichtige Themen.

Auch internationale Einkäufer nutzten die Messe für die Suche nach Produzenten, wie Social Cloud Co., Dont Give Up Co., und WHYNOTCo. aus Italien.

Kollektionen mit starkem Design, innovative und individuelle Produkte standen im Fokus der Kunden. Ein grundlegender Trend sind gestiegene Qualitätsanforderungen für alle Produktsegmente, auch für die Basisprodukte. Der Konsument wünscht sich qualitativ hochwertige Ware, Qualität vor Quantität. Das ist während der CHIC ONLINE von den Marktteilnehmern hervorgehoben worden.

Chen Dapeng resümiert: „Die digitale Premiere der CHIC ist bei allen Teilnehmern auf positive Resonanz gestoßen. Als verläßlicher Partner der Branche ist es CHICs Absicht und Zweck der Industrie und dem Handel pragmatische Unterstützung zu bieten. Wir sind überzeugt, dass Chinas Modeindustrie neu gestartet ist.“

02.05.2020

NCTO: Buy American Policy for Personal Protective Equipment

National Council of Textile Organizations (NCTO) President and CEO Kim Glas issued a statement, urging the government to institute Buy American policy changes to help bolster U.S. manufacturers producing personal protective equipment (PPE) for frontline workers battling the COVID-19 pandemic.

“If the government is sincere about reconstituting a U.S. production chain for medical personal protective equipment (PPE) to resolve the drastic shortages we are experiencing during the current pandemic, it is going to have to make key policy changes to help incentivize domestic production. A strong Buy American mandate for these vital healthcare materials needs to be instituted for all federal agencies, coupled with other reasonable production incentives, to help ensure a strong U.S.  manufacturing base for these essential products.

National Council of Textile Organizations (NCTO) President and CEO Kim Glas issued a statement, urging the government to institute Buy American policy changes to help bolster U.S. manufacturers producing personal protective equipment (PPE) for frontline workers battling the COVID-19 pandemic.

“If the government is sincere about reconstituting a U.S. production chain for medical personal protective equipment (PPE) to resolve the drastic shortages we are experiencing during the current pandemic, it is going to have to make key policy changes to help incentivize domestic production. A strong Buy American mandate for these vital healthcare materials needs to be instituted for all federal agencies, coupled with other reasonable production incentives, to help ensure a strong U.S.  manufacturing base for these essential products.

Our government already has an existing example of such a mandate that serves as an excellent model. The U.S. Department of Defense operates under a fiber-to-finished product Buy American rule for military textiles. This rule ensures that the vital textile materials our U.S. warfighters depend upon, come from a secure domestic production chain that cannot be severed during a military emergency by offshore entities.

There is a bipartisan call for action as members of Congress on both sides of the aisle have begun to acknowledge the need for these types of reasonable and essential policy changes.

Anything short of fully instituting domestic purchase requirements through Executive Order and other legislative initiatives will ensure that PPE production through U.S. supply chains that have been created overnight don’t evaporate as soon as this crisis is over.  

In the midst of the crisis, our failure to confront this challenge will allow for a repeat of the sins of the past that allowed sourcing agents to offshore the entire production of medical PPE in search of lucrative profits. While chasing the lowest cost import may have seemed cost effective at the time, these past few months have demonstrated that we paid a deadly price through this approach by jeopardizing the very lives of frontline medical personnel that are fighting the pandemic.   

This is a national security issue. It’s also a vital healthcare issue and it is decision time for U.S. policymakers. If our country is to be prepared for future deadly pandemics such as the one it is now facing, reasonable policy changes need to be implemented to ensure that we strengthen our domestic supply chain to address America’s security, safety and healthcare requirements.”


NCTO is a Washington, DC-based trade association that represents domestic textile manufacturers, including artificial and synthetic filament and fiber producers. 

Source:

NCTO

Logo oerlikon
Oerlikon expands labatory capacities
30.04.2020

Oerlikon Nonwoven expands it laboratory nonwovens production capacities

Materials for in excess of one million protective masks
Within the context of supporting the critical infrastructure in Germany, Oerlikon Nonwoven immediately began converting its laboratory systems in Neumünster to manufacture nonwovens at the end of March. With this, only small local businesses and companies were initially supported in the manufacture of oronasal masks.
With the laboratory system at the R&D Center material for more than one million protective masks a month can be manufactured.

The laboratory has meanwhile run out of raw materials and new orders for replacement materials had to be placed before Easter – with current delivery times of approx. 3 weeks. This will allow production to be resumed, and even considerably expanded, in May.
The laboratory system is now once again being deployed to produce nonwovens that will be used to make more than million face masks / oronasal masks a month. “We will not be manufacturing the masks ourselves. We have meanwhile found both corresponding partner companies and also private individuals demanding nonwovens”, adds Andreas Frisch, commenting on the developments.

Materials for in excess of one million protective masks
Within the context of supporting the critical infrastructure in Germany, Oerlikon Nonwoven immediately began converting its laboratory systems in Neumünster to manufacture nonwovens at the end of March. With this, only small local businesses and companies were initially supported in the manufacture of oronasal masks.
With the laboratory system at the R&D Center material for more than one million protective masks a month can be manufactured.

The laboratory has meanwhile run out of raw materials and new orders for replacement materials had to be placed before Easter – with current delivery times of approx. 3 weeks. This will allow production to be resumed, and even considerably expanded, in May.
The laboratory system is now once again being deployed to produce nonwovens that will be used to make more than million face masks / oronasal masks a month. “We will not be manufacturing the masks ourselves. We have meanwhile found both corresponding partner companies and also private individuals demanding nonwovens”, adds Andreas Frisch, commenting on the developments.

Boom in orders
Furthermore, Oerlikon Nonwoven has also fired up the production of the machines and systems used for its meltblown technology. The demand from Germany, Europe and the rest of the world has quickly
secured the company a high in orders..
We will be commissioning the first meltblown system at the site of a leading Western European nonwovens producers in the second quarter of 2020. The capacities for respiratory masks available in Europe to date are predominantly manufactured on Oerlikon
Nonwoven systems.

Source:

Marketing, Corporate Communications & Public Affairs

Logo Mimaki
Mimaki starts to produce masks
29.04.2020

Energiapura: production of masks

Energiapura – Production of reusable, customised protective masks that are also fashion accessories

Energiapura – Production of reusable, customised protective masks that are also fashion accessories

  • The Italian company, a specialist manufacturer of functional sportswear, conducted research and began producing masks in response to the COVID-19 crisis
  • Using Mimaki sublimation printers, the masks can be customised, getting away from their connotation with hospitals and transforming them into a fashion accessory

From functional sportswear to combatting the spread of the Coronavirus: Energiapura, an Italian company has developed a mask that meets the Class I medical device requirements. The EP PA 2020 (Energiapura Pure Air) facial device, optimised for air filtering and breathability, provides protection while working, and can be reused. But Energiapura has gone even further, branding and customising the masks with sublimation printing.
The EP PA 2020 mask, compliant with 93/42 EEC Medical Devices – Class I washable, meets the essential requirements of UNI EN 14683:2019. Having redirected the manufacturing process, Energiapura is now stepping up production levels to meet the rising demand from hospitals, pharmacies, chemists, companies and consumers.

Pure Air, Energiapura’s mask
The EP PA 2020 is based on a functional concept: protection, breathability and reusability are the main principles. EP PA 2020 is made up of three layers of fabric: the first, the outer layer, is DWR-treated polyester, the second is TNT polyester, providing a filtering function, and the third, which comes into contact with the face, is polyester containing special fibres, such as coolmax and carbon.  Therefore it can be reused via normal washing and steam ironing, which also sterilises it.
The CEO of Enegiapura, Alberto Olivietto explains the idea of the customisation of the mask: “We wanted to disassociate our masks from the hospital image. By decorating them with company branding and designs provided by customers.” This is where the Mimaki JV300 wide-format printer comes in.

 

More information:
corona virus face masks
Source:

(c) Mimaki Europe B.V.

Primary Vittorio Segramora of San Gerardo Hospital with a nurse wearing one of the 1,800 donated gowns (c) GB Network
Primary Vittorio Segramora of San Gerardo Hospital with a nurse wearing one of the 1,800 donated gowns
29.04.2020

Call to action of the fashion world

  • Diana, Giusy, Simona and Marina. The call to action of the fashion world was born from four women engaged in the field of sustainability. On the occasion of Fashion Revolution Week, we tell you their story and the results achieved

A task force of Italian textile companies active in our area supported the first call to action launched at the fashion world by four women who have always been involved in the field of sustainability. The appeal launched on March 19th by the green journalist Diana de Marsanich, Giusy Bettoni, founder and CEO of C.L.A.S.S.

  • Diana, Giusy, Simona and Marina. The call to action of the fashion world was born from four women engaged in the field of sustainability. On the occasion of Fashion Revolution Week, we tell you their story and the results achieved

A task force of Italian textile companies active in our area supported the first call to action launched at the fashion world by four women who have always been involved in the field of sustainability. The appeal launched on March 19th by the green journalist Diana de Marsanich, Giusy Bettoni, founder and CEO of C.L.A.S.S. (Creativity Lifestyle and Sustainable Synergy)the eco multi-platform hub specialized in integrating a new generation of eco values into fashion, products and companies, Simona Roveda, Editorial Director and Director of Institutional Communication of LifeGate and Marina Spadafora, Italian Country Coordinator of Fashion Revolution and currently collaborating with Luxury Fashion Brands to implement responsible strategies in their companies have luaunched a call-to-action project which has brought together textile companies to manufacture PPE garments for the medical staff working in San Gerardo Hospital in Monza, near Milan.

The companies that answered the call-to-action are: Filo d’Oro, Mantero, ROICA™ by Asahi Kasei, C.L.A.S.S. (Creativity Lifestyle and Sustainable Synergy) e Zerobarracento, Iluna Group, Lg Electronics, Jimmy Lion, Personal Genomics, Isamar Holyday Village, Marcolin Eyewear, Maglificio Ripa.

During the last weeks the 4 women collected about 1,800 non-drip cotton and non-woven TNT gowns for sanitary use, about 400 protective masks for multipurpose washable, bacteriostatic, breathable and water-repellent prevention, 1,000 washable cotton surgical caps, 150 complete protective googles eye masks, two microwave ovens for hospital departments to offer support to medical and healthcare personnel by helping them in the few breaks during the grueling shifts of this period, a supply of samples of cotton socks, 300 cotton masks + polyester outer layer, water-repellent and antibacterial, and free weekly stays made available to doctors, nurses, civil protection personnel and families with related children involved in the Covid-19 pandemic.

Source:

GB Network Marketing Communications Srl

 

27.04.2020

Using chemistry to fight Covid-19: CHT Group expands product portfolio

In mid-March, CHT Germany GmbH, which specializes in specialty chemicals, took up production and distribution of hand disinfectant. Now the company is expanding its product portfolio by adding important medical supplies that can help fight Covid-19 (SARS-CoV-2). Starting immediately, CHT is providing its business customers with surface disinfectant, textile supplies for medical protective wear as well as supplies for test kits and face masks.

In mid-March, CHT Germany GmbH, which specializes in specialty chemicals, took up production and distribution of hand disinfectant. Now the company is expanding its product portfolio by adding important medical supplies that can help fight Covid-19 (SARS-CoV-2). Starting immediately, CHT is providing its business customers with surface disinfectant, textile supplies for medical protective wear as well as supplies for test kits and face masks.

Following increased demand for disinfectant in the wake of the new coronavirus, the CHT Group began already a month and a half ago to produce hand disinfectant at its factory in Dußlingen. Since then, more of its factories around the world had joined in. Now the CHT Group is complementing this offering by producing its own surface disinfectant based on ethanol. As with the hand disinfectant, the production of the surface disinfectant received a special approval, based on the expanded general ruling by the German Federal Agency  for Chemicals (BAuA). Both types of disinfectant use publicly available standard formulas for alcohol-based disinfectant from the World Health Organization (WHO). The sale of CHT’s surface disinfectant, which is available in 5-, 10- and 30-liter canisters, is exclusively for use by industry customers.

In addition, the CHT Group is manufacturing a range of textile-relevant products that provide protection from Covid-19. These include functional supplies for face masks for medical protective wear, as well as flocking for test kits. Through these offerings, the CHT Group also wants to support the textile sector, which has been strongly affected by the crisis.

More information:
surface disinfectant CHT Gruppe
Source:

CHT Gruppe

24.04.2020

Lenzing AG and Palmers Textil AG found Hygiene Austria LP GmbH

Center of competence for hygiene established in Wiener Neudorf to support Austria and the EU in the Covid-19 crisis for the industrial production of high-quality protective masks with a monthly capacity of 12 million pieces.

Lenzing AG and Palmers Textil AG found “Hygiene Austria LP GmbH”, in which Lenzing AG holds 50.1% and Palmers Textil AG 49.9%. The newly founded company will start producing and selling protective masks for the domestic and European markets from May 2020.

Over the past few weeks, Lenzing AG and Palmers Textil AG have invested several million euros in a modern production infrastructure at the Wiener Neudorf location and secured the corresponding raw materials for protective masks production. In a first step, the company produces so-called mouth-nose protective masks (MNS) and surgical protective masks of class EN14683. Hygiene Austria LP GmbH plans to increase its capacities to over 25 million masks per month over the next few weeks and to expand this business geographically as well.

Center of competence for hygiene established in Wiener Neudorf to support Austria and the EU in the Covid-19 crisis for the industrial production of high-quality protective masks with a monthly capacity of 12 million pieces.

Lenzing AG and Palmers Textil AG found “Hygiene Austria LP GmbH”, in which Lenzing AG holds 50.1% and Palmers Textil AG 49.9%. The newly founded company will start producing and selling protective masks for the domestic and European markets from May 2020.

Over the past few weeks, Lenzing AG and Palmers Textil AG have invested several million euros in a modern production infrastructure at the Wiener Neudorf location and secured the corresponding raw materials for protective masks production. In a first step, the company produces so-called mouth-nose protective masks (MNS) and surgical protective masks of class EN14683. Hygiene Austria LP GmbH plans to increase its capacities to over 25 million masks per month over the next few weeks and to expand this business geographically as well.

The demand for high-quality MNS and respiratory masks for medical personnel is increasing rapidly, and there is real competition on the international market for these products. In order to sustainably secure domestic supply now and in the future and to strengthen the business location, the two companies Lenzing AG and Palmers Textil AG have now set a milestone with their own competence center for hygiene based in Austria.

Hygiene Austria LP GmbH thus makes a significant contribution to combating the Covid-19 pandemic and ensures the long-term supply of these critical goods in Austria in high quality.

Source:

Lenzing AG

Logo oerlikon
Oerlikon blickt positiv in die Zukunft
23.04.2020

Oerlikon Manmade Fibers segment looking positively towards the future during the coronavirus pandemic

Staggered in terms of timing and with varying magnitude, the global spread of coronavirus is impacting the development of the regional economies in the core markets of the Manmade Fibers segment of the Swiss Oerlikon Group.
The sales markets for manmade fiber systems and equipment have been primarily located in China, India and Turkey for many years now. Together, these markets – above all China – make up the lion’s share of the project landscape at Oerlikon Manmade Fibers. And this is paying positive dividends at the moment. Because the production facilities of the major manmade fiber manufacturers in
China have been systematically fired up again over the past few weeks, with capacity utilization increasing consistently.

Staggered in terms of timing and with varying magnitude, the global spread of coronavirus is impacting the development of the regional economies in the core markets of the Manmade Fibers segment of the Swiss Oerlikon Group.
The sales markets for manmade fiber systems and equipment have been primarily located in China, India and Turkey for many years now. Together, these markets – above all China – make up the lion’s share of the project landscape at Oerlikon Manmade Fibers. And this is paying positive dividends at the moment. Because the production facilities of the major manmade fiber manufacturers in
China have been systematically fired up again over the past few weeks, with capacity utilization increasing consistently.

Going against the flow
The Segment CEO, Georg Stausberg explains the reason: “Long before the coronavirus situation developed, the major manmade fiber manufacturers in China had decided to reverse-integrate their production chains to include petrochemicals in order to expand their portfolios with targeted investments, to reduce their dependence on a ,single product’, to optimize their costs and ultimately to acquire greater control over margins in a global volume business”.
Similar processes and decisions – albeit not on the same scale as in China – have also
been detected at the large manmade fiber manufacturers in India and Turkey. Even though businesses in India and Turkey are presently still temporarily severely impacted by the coronavirus situation, their long-term commitment cannot however be questioned, as the company-internally-agreed plans will be systematically implemented moving forward.

Long-term investments of global market players
All this has recently resulted in increased demand for spinning and texturing systems – just like those supplied by total solutions provider Oerlikon Manmade Fibers with its
Oerlikon Barmag, Oerlikon Neumag and Oerlikon Nonwoven product brands.
“The investments in petrochemical systems are based on long-term strategic considerations and are resulting – even during the coronavirus pandemic – neither in short- and medium-term economic dips, nor in changed customer behavior. (...)”, states Segment-CEO Georg Stausberg.
As a result of Oerlikon Manmade Fibers delving into the digital age years ago, the segment has experienced the intensive and short-term benefit from all the measures, in part also in its processing of customer projects.

Source:

Marketing, Corporate Communications
& Public Affairs

Logo monforts
Logo monforts
21.04.2020

Monforts: Industrial-scale testing for new PPE finishes

In the current fight against Covid-19, a number of formulators of textile finishing chemicals have rushed out new antiviral and antimicrobial treatments intended for PPE (personal protective equipment) such as face masks and medical gowns and drapes.

These finishing chemicals have naturally already been thoroughly tested in laboratories and their effectiveness verified at laboratory or pilot scale. However, they are new to many manufacturers of textiles and nonwovens now preparing to use them on an industrial level.

A lot of companies changed, due to the current situation their usual manufacturing programmes to the production of PPE items. “We have experts on hand at our operational Advanced Technology Centre (ATC) here in Germany, to help any of our customers to rapidly transition to new finishing techniques and treatments they may not be familiar with, and to run trials on their behalf, should they require this assistance.”, states the vice president of Monforts, Klaus Heinrichs.

In the current fight against Covid-19, a number of formulators of textile finishing chemicals have rushed out new antiviral and antimicrobial treatments intended for PPE (personal protective equipment) such as face masks and medical gowns and drapes.

These finishing chemicals have naturally already been thoroughly tested in laboratories and their effectiveness verified at laboratory or pilot scale. However, they are new to many manufacturers of textiles and nonwovens now preparing to use them on an industrial level.

A lot of companies changed, due to the current situation their usual manufacturing programmes to the production of PPE items. “We have experts on hand at our operational Advanced Technology Centre (ATC) here in Germany, to help any of our customers to rapidly transition to new finishing techniques and treatments they may not be familiar with, and to run trials on their behalf, should they require this assistance.”, states the vice president of Monforts, Klaus Heinrichs.

The three lines at the ATC situated at the Monforts HQ in Mönchengladbach, are of a true industrial scale and trialling new products on them goes beyond lab or pilot plant testing to rapidly identify any problems that might occur once full production is underway.

 

More information:
Monforts corona virus
Source:

AWOL Media